William Blair on Fidelity National Info Services (FIS): 'Strong Set of Assets With Compelling Valuation' Mar 13, 2026 03:45PM
William Blair Reiterates Outperform Rating on PAR Technology (PAR) after convertible debt offering announcement Mar 13, 2026 01:12PM
William Blair Reiterates Outperform Rating on Dave Inc (DAVE): 'We recommend investors accumulate DAVE shares' Mar 13, 2026 10:57AM
William Blair: 'The pace at which Carvana is growing puts it in rare air' Mar 13, 2026 10:46AM
William Blair Reiterates Outperform Rating on ServiceTitan (TTAN): 'we view valuation as attractive' Mar 13, 2026 09:08AM
View Older Stories

Mar 13, 2026 08:06AM William Blair Reiterates Market Perform Rating on El Pollo Loco (LOCO) following earnings report
Mar 13, 2026 04:32AM William Blair Downgrades PagerDuty (PD) to Market Perform
Mar 12, 2026 05:04PM William Blair Reiterates Outperform Rating on VSE Corporation (VSEC): "We view today’s 7% stock drawdown as a buying opportunity"
Mar 12, 2026 04:29PM Form N-CEN WILLIAM BLAIR FUNDS For: Dec 31
Mar 12, 2026 04:01PM Xenon Pharmaceuticals closes $747.5 million public offering
Mar 12, 2026 04:01PM Dianthus Therapeutics completes $719 million public offering
Mar 12, 2026 10:35AM William Blair Reiterates Outperform Rating on Tenaya Therapeutics Inc (TNYA): "entering 2026 with increasing momentum"
Mar 12, 2026 09:17AM William Blair Reiterates Market Perform Rating on UiPath Inc. (PATH): "incrementally encouraged"
Mar 12, 2026 08:45AM William Blair Reiterates Outperform Rating on Aveanna Healthcare Holdings Inc (AVAH) following acquisition announcement
Mar 12, 2026 08:31AM Oxford Lane Capital announces preferred stock offering
Mar 12, 2026 06:02AM William Blair: 'We like CRCL for long-term investors'
Mar 11, 2026 04:41PM William Blair Reiterates Outperform Rating on AppLovin Corp (APP) following meeting with management
Mar 11, 2026 04:11PM William Blair Reiterates Market Perform Rating on Sprinklr Inc (CXM): "a lot to prove on the execution front"
Mar 11, 2026 05:43AM William Blair: 'increasing likelihood that Oracle sees significant earnings growth acceleration over the coming years'
Mar 10, 2026 10:54PM Dianthus Therapeutics prices $625 million public stock offering
Mar 10, 2026 10:39PM Xenon Pharmaceuticals prices $650 million stock offering at $57 per share
Mar 10, 2026 02:34PM William Blair Reiterates Outperform Rating on Veeva Systems (VEEV) amid Ostro acquisition
Mar 10, 2026 02:25PM William Blair Reiterates Outperform Rating on Tenax Therapeutics (TENX): "continue to believe positive top-line results from LEVEL have the potential to drive multifold upside"
Mar 10, 2026 02:00PM Medline completes $3.5 billion secondary stock offering
Mar 10, 2026 12:19PM William Blair Reiterates Outperform Rating on Exagen (XGN) following Q4 results
Mar 10, 2026 09:29AM William Blair Reiterates Outperform Rating on LENZ Therapeutics Inc (LENZ): "continue to believe VIZZ holds blockbuster potential"
Mar 10, 2026 08:29AM William Blair Reiterates Outperform Rating on Standex International (SXI) following meetings with management
Mar 10, 2026 06:34AM William Blair Starts BridgeBio Pharma (BBIO) at Outperform
Mar 9, 2026 05:00PM MiniMed closes IPO raising $538 million at $20 per share
Mar 9, 2026 04:57PM William Blair Reiterates Outperform Rating on Nayax (NYAX) following earnings
Mar 9, 2026 04:19PM William Blair Reiterates Outperform Rating on StoneX Group Inc. (SNEX): "current price looks highly attractive"
Mar 9, 2026 04:01PM Dianthus Therapeutics announces $400 million public stock offering
Mar 9, 2026 04:01PM Xenon Pharmaceuticals announces $500 million public offering
Mar 9, 2026 03:12PM William Blair Reiterates Outperform Rating on Kalaris (KLRS): "we see blockbuster potential for TH103 in nAMD"
Mar 9, 2026 02:44PM William Blair Reiterates Outperform Rating on Microsoft (MSFT) following product announcements
Mar 9, 2026 02:37PM William Blair Reiterates Market Perform Rating on ULTA Beauty (ULTA) ahead of earnings
Mar 9, 2026 02:30PM William Blair: 'We expect Microsoft to continue expanding its enterprise wallet share'
Mar 9, 2026 01:14PM William Blair Reiterates Outperform Rating on Crawford & Company (CRD-B): "Significant upside is possible"
Mar 9, 2026 11:52AM William Blair Reiterates Outperform Rating on Abbvie (ABBV): "competitive across the amylin class"
Mar 9, 2026 09:00AM William Blair Downgrades TalkSpace (TALK) to Market Perform
Mar 9, 2026 08:26AM William Blair Reiterates Outperform Rating on Xenon Pharmaceuticals (XENE): "we see further room for upside"
Mar 9, 2026 08:15AM William Blair Reiterates Outperform Rating on Korn/Ferry (KFY) following Q3 results
Mar 9, 2026 08:11AM William Blair Reiterates Outperform Rating on Dianthus Therapeutics (DNTH): "remain bullish here"
Mar 9, 2026 08:01AM William Blair Reiterates Outperform Rating on ARS Pharmaceuticals Inc (SPRY) following Q4 results
Mar 9, 2026 07:41AM William Blair: '$15 move in oil can cause FCF yield to more than double'
Mar 9, 2026 07:30AM Korro Bio raises $85 million in oversubscribed private placement
Mar 9, 2026 06:10AM William Blair Starts Jade Biosciences (JBIO) at Outperform
Mar 6, 2026 03:33PM William Blair Reiterates Outperform Rating on Amprius Technologies (AMPX): "best-positioned arms dealer to supply this burgeoning industry"
Mar 6, 2026 03:32PM William Blair Reiterates Outperform Rating on Stitch Fix, Inc. (SFIX): "Pullback Creates Compelling Entry Point"
Mar 6, 2026 09:03AM William Blair Reiterates Outperform Rating on Crescent Energy (CRGY) following convertible notes offering announcement
Mar 6, 2026 07:06AM William Blair Downgrades Zealand Pharma A/S (ZEAL:DC) (ZEAL) to Market Perform, Removed from Analyst Conviction List
Mar 6, 2026 06:28AM William Blair: 'we believe Marvell is well positioned to grab its fair share of the AI infrastructure wallet'
Mar 6, 2026 01:49AM Ingram Micro prices secondary offering at $22.25 per share
Mar 5, 2026 07:34PM MiniMed prices IPO at $20 per share, raising $560 million
Mar 5, 2026 05:05PM Form 497K WILLIAM BLAIR FUNDS
View Older Stories